Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitro

BACKGROUND: RNA interference technology has shown high therapeutic potential for cancer treatment. However, serum instability, poor tissue permeability and non-specific uptake of short interfering RNA (siRNA) limit its administration in vivo. To overcome these limitations and improve the specificity...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Shanshan, Zhang, Xiaoyan, Chen, Jun, Zhou, Jiabing, Zheng, Yufang, Xu, Congjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843555/
https://www.ncbi.nlm.nih.gov/pubmed/24252539
http://dx.doi.org/10.1186/1757-2215-6-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843555/
https://www.ncbi.nlm.nih.gov/pubmed/24252539
http://dx.doi.org/10.1186/1757-2215-6-80

Ejemplares similares